Watson Investigational Site 158 — Moorestown, New Jersey

Watson Investigational Site 158 is a clinical research site located in Moorestown, New Jersey, United States 08057.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Watson Investigational Site 158 has participated in 1 clinical trials.

Therapeutic areas: Leiomyoma, Uterine Hemorrhage.

Sponsors: Allergan.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Watson Investigational Site 158?

Watson Investigational Site 158 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Watson Investigational Site 158 conducted?

Watson Investigational Site 158 has 1 clinical trials on record. Their work covers Leiomyoma, Uterine Hemorrhage.

Is Watson Investigational Site 158 accredited by Crixeo Health?

Watson Investigational Site 158 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Watson Investigational Site 158?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.